November 06, 2018
Nordic Nanovector ASA: Results for the Third Quarter 2018
Media
November 05, 2018
Additional steps towards the commercialization of Ygalo®
November 05, 2018
EXTRAORDINARY GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)
November 05, 2018
Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference
November 02, 2018
Nordic Nanovector Announces First Patient Dosed in Archer-1 Trial of Betalutin® plus Rituximab in Follicular Lymphoma
November 01, 2018
Vicore Pharma’s rights issue registered – conversion of BTA to shares
November 01, 2018
Nordic Nanovector: Promising results from preclinical studies with a novel CD37-targeted alpha therapy for B-cell tumours to be presented at ASH
November 01, 2018
Nordic Nanovector highlights promising clinical results from Phase 1/2 trial of Betalutin® in relapsed/refractory indolent non-Hodgkin’s lymphoma
November 01, 2018
Oncopeptides to present updated data from the two ongoing trials ANCHOR and HORIZON in patients with RRMM at ASH in December 2018
November 01, 2018
BONESUPPORT HOLDING AB (publ) – Q3 2018 Interim Report – invitation to conference call and webcast